Cell Point LLC - Company Review
SummaryCell Point LLC - Company Review
Summary
Cell>Point LLC (Cell>Point) is a biopharmaceutical company which offers therapeutic compounds. The company develops intra-nuclear molecular metabolic imaging and intra-nuclear target therapy for the diagnosis, staging, treatment and post therapy assessment of oncology, cardiology and ischemic based diseases. Its pipeline products include oncardia, platinum-EC-G, DTPA-Gilpizide, N4 Technology, EC Metronidazole, and Ga-Ec-G. Cell>Point provides conjugate compound, Oncardia, completed a Phase 3 lung cancer imaging trial and a Phase 2b trial to diagnose the presence and extent of Ishemia viability. The company also offers compounds in preclinical development stage including N4 compound for the treatment of depression, neuroendocrine tumors and Alzheimer’s disease and the Beta Cell target specific compound for diabetes imaging. Cell>point is headquartered in Centennial, Colorado, the US.
This comprehensive company report of Cell Point LLC provides you with company's businesses and operations information.
The profile contains critical company information including,
- Company Overview - A detailed description of the company's operations and business divisions.
- Major products and services - A list of major products, services and brands of the company.
- Key competitors - A list of key competitors to the company.
- Key employees - A list of the key executives of the company.
- Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
GlobalData is a one-stop solution for actionable insight into the pharmaceutical and medical device sectors. Together with the best team of researchers, analysts, epidemiologists and consultants, and an unmatched suite of proprietary databases, we provide high-quality, accurate and transparent insight that can help you achieve growth and increase business value.
Our valuable research and consulting solutions ensure you stay at the forefront of the industry by integrating accurate market forecasts and healthcare analytics on the latest trends and developments. Among other benefits, our informed healthcare industry perspectives have assisted businesses based across the pharmaceuticals, biotechnology and medical equipment markets in making strategic decisions that have increased the value of their products and services.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.